Status:
COMPLETED
Exercise in Patients With Glioblastoma
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Canadian Cancer Society (CCS)
University of Toronto
Conditions:
Glioblastoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients with newly-diagnosed GBM will be given personalized exercise regimes during concurrent chemo-radiation and up to 3 months later. Study aims are to investigate the feasibility and preliminary ...
Detailed Description
Background: Glioblastoma (GBM) is the most common malignant glioma in adults, with a very poor prognosis, limited new treatment options, and neurological sequelae, including physical and cognitive dec...
Eligibility Criteria
Inclusion
- newly diagnosed glioblastoma
- fluent in English
- scheduled to be treated with concurrent chemoradiation (or within 2 weeks of starting treatment)
Exclusion
- brain metastases secondary to non-central nervous system cancer
- less than 18 years old
- receiving treatment at a location other than the Princess Margaret Cancer Centre
- deemed unfit to exercise by a study oncologist
- lack of fluency in English
- psychiatric or neurological disorders that could interfere with participation
Key Trial Info
Start Date :
August 29 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 23 2021
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT03390569
Start Date
August 29 2017
End Date
December 23 2021
Last Update
April 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Margaret Hospital, University Health Network
Toronto, Ontario, Canada, M5G 2M9